Cargando…

DNAJB4 promotes triple-negative breast cancer cell apoptosis via activation of the Hippo signaling pathway

INTRODUCTION: Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast cancer without effective targeted therapies. DNAJB4 (Dnaj heat shock protein family (Hsp40) member B4) is a member of the human heat shock protein family (Hsp40). The clinical significance of DNAJB4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Fang, Mo, Linglong, Pan, Xiaofeng, Yang, Ziquan, Huang, Haoyu, Zhu, Liangyu, Wang, Yingying, Jiang, Guoqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070573/ https://www.ncbi.nlm.nih.gov/pubmed/37012515 http://dx.doi.org/10.1007/s12672-023-00645-y

Ejemplares similares

DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway
por: Chen, Yanru, et al.
Publicado: (2023)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1
por: Kim, Hye-Youn, et al.
Publicado: (2021)

ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling
por: Liu, Yun, et al.
Publicado: (2021)

Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway
por: Liu, Peng, et al.
Publicado: (2022)

miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling: miR-1205/DNAJB1 reverses docetaxel chemoresistance in TNBC
por: Yin, Yongxiang, et al.
Publicado: (2021)

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells
por: Deshayes, Natasja, et al.
Publicado: (2019)

Upstream regulators of the Hippo pathway
por: Yu, Fa-Xing, et al.
Publicado: (2012)

LncRNA GHET1 Promotes Hypoxia-Induced Glycolysis, Proliferation, and Invasion in Triple-Negative Breast Cancer Through the Hippo/YAP Signaling Pathway
por: Wang, Yu, et al.
Publicado: (2021)

DNAJB6b is Downregulated in Synucleinopathies
por: Folke, Jonas, et al.
Publicado: (2021)

On the micelle formation of DNAJB6b
por: Carlsson, Andreas, et al.
Publicado: (2023)

The Inactivation of Hippo Signaling Pathway Promotes the Development of Adenomyosis by Regulating EMT, Proliferation, and Apoptosis of Cells
por: Jin, Tingting, et al.
Publicado: (2023)

Role of the Hippo Pathway in Fibrosis and Cancer
por: Kim, Cho-Long, et al.
Publicado: (2019)

Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
por: Wang, Zhonghao, et al.
Publicado: (2020)

Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
por: Soyama, Hirotoshi, et al.
Publicado: (2022)

Hippo pathway inhibition promotes metabolic adaptability and antioxidant response in myoblasts
por: Liu, Qi, et al.
Publicado: (2023)

DNAJB7 is dispensable for male fertility in mice
por: Bai, Shun, et al.
Publicado: (2023)

The Hippo signaling pathway: from multiple signals to the hallmarks of cancers: Hippo pathway: from multiple signals to the hallmarks of cancers
por: Zhu, Ning, et al.
Publicado: (2023)

The palmitoyltransferase Approximated promotes growth via the Hippo pathway by palmitoylation of Fat
por: Matakatsu, Hitoshi, et al.
Publicado: (2017)

Expression of DNAJB12 or DNAJB14 Causes Coordinate Invasion of the Nucleus by Membranes Associated with a Novel Nuclear Pore Structure
por: Goodwin, Edward C., et al.
Publicado: (2014)

Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy
por: Ruggieri, Alessandra, et al.
Publicado: (2015)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells
por: Chang, Yu, et al.
Publicado: (2019)

Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D
por: Sandell, Satu, et al.
Publicado: (2016)

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Vici, Patrizia, et al.
Publicado: (2016)

Porcine DNAJB6 promotes PCV2 replication via enhancing the formation of autophagy in host cells
por: Han, Cong, et al.
Publicado: (2020)

A novel recessive mutation affecting DNAJB6a causes myofibrillar myopathy
por: Qian, Fang-Yuan, et al.
Publicado: (2021)

Inactivation of the Hippo tumor suppressor pathway promotes melanoma
por: Vittoria, Marc A., et al.
Publicado: (2022)

Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells
por: Hwang, Sung-Min, et al.
Publicado: (2014)

Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects
por: Kilanowska, Agnieszka, et al.
Publicado: (2022)

The Hippo pathway mediates Semaphorin signaling
por: Meng, Zhipeng, et al.
Publicado: (2022)

Loss of the emei tumor suppressor promotes tumorigenesis via the JNK and Hippo pathway
por: Yang, Shuai, et al.
Publicado: (2022)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Reply: The role of DNAJB2 in amyotrophic lateral sclerosis
por: Chen, Han-Jou, et al.
Publicado: (2016)

DNAJB9 Is Not Transcriptionally Upregulated in the Glomerulus in Fibrillary Glomerulonephritis
por: Avasare, Rupali S., et al.
Publicado: (2019)

Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response
por: Andeen, Nicole K., et al.
Publicado: (2022)

DNAJB9-Positive Tubulointerstitial-Predominant Fibrillary Nephritis
por: Bourhis, Amelie, et al.
Publicado: (2023)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v91asbnj07fviej8nhun7i501